DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin Hydrochloride) - Current Clinical Trials

 
 



Epirubicin Related Clinical Trials

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [Terminated]

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Recruiting]

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients [Recruiting]

Study of Docetaxel in Breast Cancer Patients [Completed]

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients [Recruiting]

Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer [Active, not recruiting]

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer [Recruiting]

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer [Recruiting]

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer [Terminated]

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer [Recruiting]

REAL 3 Version 2.0: Trial of the Efficacy of Epirubicin, Oxaliplatin and Capecitabine (EOX) With or Without Panitumumab in Previously Untreated Advanced Oesophago-Gastric Cancer [Recruiting]

Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer [Active, not recruiting]

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Active, not recruiting]

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors [Terminated]

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility [Active, not recruiting]

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer [Active, not recruiting]

Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast [Recruiting]

A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early [Recruiting]

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma [Active, not recruiting]

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors [Recruiting]

Early Cardiac Toxicity of Adjuvant CT in Elderly BC. [Not yet recruiting]

Cisplatin, Capecitabine, Gemcitabine Hydrochloride and Epirubicin Hydrochloride or Docetaxel in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Recruiting]

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer [Recruiting]

Epirubicin, Oxaliplatin, and Capecitabine or Docetaxel and Oxaliplatin in Treating Patients With Advanced Esophageal Cancer, Gastroesophageal Junction Cancer, or Stomach Cancer [Recruiting]

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma [Recruiting]

EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients [Completed]

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Completed]

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Recruiting]

A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Completed]

Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel [Active, not recruiting]

Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Completed]

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer [Suspended]

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer [Completed]

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Active, not recruiting]

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Suspended]

Docetaxel and Epirubicin in Advanced Gastric Cancer [Recruiting]

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer [Active, not recruiting]

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer [Active, not recruiting]

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Completed]

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies [Recruiting]

Phase I Combination w/ Epirubicin [Recruiting]

ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction [Recruiting]

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Study of Epirubicin (PharmorubicinŽ), Carboplatin (ParaplatinŽ) and Capecitabine (XelodaŽ) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Recruiting]

Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer [Recruiting]

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 [Recruiting]

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes [Active, not recruiting]

Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer [Completed]

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC [Recruiting]

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer [Active, not recruiting]

Melanoma Epirubicin Sulindac Trial: Sulindac in Combination With Epirubicin in Patients With Advanced Melanoma [Recruiting]

Neo-Adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Active, not recruiting]

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma [Completed]

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment [No longer recruiting]

Gemcitabine/Cisplatin Vs Gemcitabine/Epirubicin for NSCLC [Recruiting]

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer [Recruiting]

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer [Recruiting]

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer [Recruiting]

Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer [Recruiting]

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer [Active, not recruiting]

Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer [Not yet recruiting]

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer [Active, not recruiting]

Neoadjuvant Endostatin and Chemotherapy for Breast Cancer [Recruiting]

Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer [Recruiting]

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer [Recruiting]

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer [Recruiting]

Phase I- Lapatinib and Epirubicin Study [Recruiting]

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Recruiting]

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [Recruiting]

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer [Recruiting]

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin [Recruiting]

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach [No longer recruiting]

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma [No longer recruiting]

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer [No longer recruiting]

Pre-Operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma [Recruiting]

Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) [Recruiting]

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Active, not recruiting]

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Completed]

Combination Chemotherapy in Treating Women With Resected Breast Cancer [No longer recruiting]

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Recruiting]

Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer [No longer recruiting]

Neoadjuvant ECX Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus [Recruiting]

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery [No longer recruiting]

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer [Recruiting]

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer [Recruiting]

Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma [Recruiting]

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Recruiting]

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients [Recruiting]

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer [Recruiting]

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer [Recruiting]

The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer [Not yet recruiting]

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer [Recruiting]

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer [Recruiting]

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer [Recruiting]

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014